Tresmares Capital, a leading investment platform in Spain, has acquired a stake in the biotechnology company Proteos Biotech, in a transaction advised by the Evergreen Legal team.
Proteos Biotech specializes in the production of recombinant enzymes, offering products with high-quality standards that are backed by various certifications and scientific research. The company develops exclusive active ingredients for its clients, incorporating the latest trends and world-leading cutting-edge technology, with an international presence in more than 50 countries.
Several partners from the firm participated in this transaction: Ignacio Freire and Luis Vegas from the Corporate department, Jacobo de la Guardia from the Tax department, and Cristina González Olivares from the Employment & Labor area. Associates Celia Gil and Marina Roji also played a key role in the operation.